0000905718-15-000805.txt : 20151002 0000905718-15-000805.hdr.sgml : 20151002 20151002160139 ACCESSION NUMBER: 0000905718-15-000805 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20151002 DATE AS OF CHANGE: 20151002 EFFECTIVENESS DATE: 20151002 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Dance Biopharm Holdings, Inc. CENTRAL INDEX KEY: 0001650840 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-248683 FILM NUMBER: 151140231 BUSINESS ADDRESS: STREET 1: 150 NORTH HILL DRIVE, SUITE 24 CITY: BRISBANE STATE: CA ZIP: 94005 BUSINESS PHONE: 415-369-9415 MAIL ADDRESS: STREET 1: 150 NORTH HILL DRIVE, SUITE 24 CITY: BRISBANE STATE: CA ZIP: 94005 FORMER COMPANY: FORMER CONFORMED NAME: Dance BioPharm Holdings, Inc. DATE OF NAME CHANGE: 20150812 D 1 primary_doc.xml X0707 D LIVE 0001650840 Dance Biopharm Holdings, Inc. 150 NORTH HILL DRIVE, SUITE 24 BRISBANE CA CALIFORNIA 94005 415-369-9415 DELAWARE SAV Holdings Corp. Dance BioPharm Holdings, Inc. Corporation true 2013 John S. Patton, Ph.D c/o Dance Biopharm Inc. 150 North Hill Drive, Suite 24 Brisbane CA CALIFORNIA 94005 Executive Officer Director Greg S. Zante c/o Dance Biopharm Inc. 150 North Hill Drive, Suite 24 Brisbane CA CALIFORNIA 94005 Executive Officer Lisa E. Porter, M.D. c/o Dance Biopharm Inc. 150 North Hill Drive, Suite 24 Brisbane CA CALIFORNIA 94005 Executive Officer Augustine P.Y. Chow, M.D. c/o Dance Biopharm Inc. 150 North Hill Drive, Suite 24 Brisbane CA CALIFORNIA 94005 Director Donald D. Huffman c/o Dance Biopharm Inc. 150 North Hill Drive, Suite 24 Brisbane CA CALIFORNIA 94005 Director Adam Stern c/o Aegis Capital Corp. 810 Seventh Ave., 18th Floor New York NY NEW YORK 10019 Director Tyler Martin, M.D. c/o Dance Biopharm Inc. 150 North Hill Drive, Suite 24 Brisbane CA CALIFORNIA 94005 Executive Officer Director Biotechnology Decline to Disclose 06b false 2015-09-30 false true true true Units consisting of common stock and warrants true At closing, our wholly owned subsidiary merged with and into Dance Biopharm Inc. (Dance), with Dance becoming our wholly-owned subsidiary. Among other merger consideration issued to Dance security holders, Dance stockholders received shares of our stock. 0 Aegis Capital Corp 15007 None None 810 SEVENTH AVENUE, 18TH FLOOR NEW YORK NY NEW YORK 10019 All States false Financial West Group, Inc. 16668 None None 4510 E. THOUSAND OAKS BLVD WESTLAKE VILLAGE CA CALIFORNIA 91362 All States false 40000000 10134033 29865967 Includes over-allotment option. Reflects only private placement consideration. false 135 5200000 true 0 Placement Agents are entitled to receive 10% cash and expense fees. Assumes maximum offering sold and commissions paid pursuant to over-allotment. Does not include warrants issuable to Placement Agents. 0 true Some of the proceeds may be used for general working capital purposes which may include payment of salaries and other fees to those listed in Item 3, as more fully set forth in the offering materials. false Dance Biopharm Holdings, Inc. /s/ John S. Patton Ph.D John S. Patton Ph.D Chief Executive Officer 2015-10-02